0001209191-14-064790.txt : 20141024
0001209191-14-064790.hdr.sgml : 20141024
20141024181001
ACCESSION NUMBER: 0001209191-14-064790
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20141022
FILED AS OF DATE: 20141024
DATE AS OF CHANGE: 20141024
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: NxStage Medical, Inc.
CENTRAL INDEX KEY: 0001333170
STANDARD INDUSTRIAL CLASSIFICATION: ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS [3845]
IRS NUMBER: 043454702
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 350 MERRIMACK STREET
CITY: LAWRENCE
STATE: MA
ZIP: 01843
BUSINESS PHONE: 978-687-4700
MAIL ADDRESS:
STREET 1: 350 MERRIMACK STREET
CITY: LAWRENCE
STATE: MA
ZIP: 01843
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Brown Robert S.
CENTRAL INDEX KEY: 0001382096
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-51567
FILM NUMBER: 141173243
MAIL ADDRESS:
STREET 1: NXSTAGE MEDICAL INC
STREET 2: 439 SOUTH UNION STREET 5TH FLOOR
CITY: LAWRENCE
STATE: MA
ZIP: 01843
FORMER NAME:
FORMER CONFORMED NAME: Brown Robert
DATE OF NAME CHANGE: 20061127
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2014-10-22
0
0001333170
NxStage Medical, Inc.
NXTM
0001382096
Brown Robert S.
C/O NXSTAGE MEDICAL, INC.
350 MERRIMACK STREET
LAWRENCE
MA
01843
0
1
0
0
President, Kidney Care
Common Stock
2014-10-22
4
M
0
1900
4.54
A
49528
D
Common Stock
2014-10-22
4
S
0
1900
14.50
D
47628
D
Common Stock
2014-10-23
4
M
0
43470
4.54
A
91098
D
Common Stock
2014-10-23
4
S
0
43470
14.53
D
47628
D
Stock Option (Right to Buy)
4.54
2014-10-22
4
M
0
1900
0.00
D
2008-04-27
2015-03-26
Common Stock
1900
43470
D
Stock Option (Right to Buy)
4.54
2014-10-23
4
M
0
43470
0.00
D
2008-04-27
2015-03-26
Common Stock
43470
0
D
This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 12, 2014.
This represents the weighted average price for shares sold in multiple transactions at prices ranging from $14.50 to $14.72, inclusive. Full information regarding the number of shares sold at each separate price within the range will be provided to NxStage Medical, Inc., any security holder of NxStage Medical, Inc. or the staff of the Securities and Exchange Commission, upon request.
/s/ Aras Lapinskas, attorney-in-fact for Robert Brown
2014-10-24